Optimising antiemesis in cancer chemotherapy.
AUTOR(ES)
Dundee, J W
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1245189Documentos Relacionados
- Points: Optimising antiemesis in cancer chemotherapy
- Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.
- Downstaging of esophageal cancer after preoperative radiation and chemotherapy.
- Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.
- Mastectomy following preoperative chemotherapy.